Safety & side effects

What we know, and the large gaps we do not

Semax has been a Russian prescription medicine since December 1994, which sounds reassuring until you look for the data behind it. There is no publicly accessible pharmacovigilance dataset in the English literature, and no long-term safety study in healthy adults.

This unit separates the mild, commonly reported effects from the genuine unknowns, explains why the Western safety record is blank, and walks through who should be most cautious. As always, this is education, not medical advice.